dabigatran has been researched along with Chronic Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barben, J; d'Athis, P; Manckoundia, P; Menu, D; Mihai, AM; Nuss, V; Putot, A; Rosay, C; Vovelle, J | 1 |
| Gong, JH; Liu, GJ; Sun, ZQ; Zhou, F | 1 |
| Fujino, T; Hamai, A; Hara, F; Harada, M; Ikeda, T; Kabuki, T; Ohara, H; Wakakura, S | 1 |
| Alves, JL; Fernandes, CJC; Gavilanes-Oleas, FA; Hoette, S; Jardim, C; Morinaga, L; Prada, LFL; Salibe Filho, W; Souza, R; Terra Filho, M | 1 |
| Basalo, MC; Ferrero-Martínez, AI; Gómez-Quintanilla, A; Guitián, A; Montero-Magan, M; Olcoz-Chiva, MT; Paredes-Galán, E; Rodríguez-Artalejo, F; Rodríguez-Pascual, C; Sharma, J; Torres-Torres, I; Vilches-Moraga, A | 1 |
| Chaudhury, P; Mentias, A; Shantha, G; Vaughan Sarrazin, MS | 1 |
| Boos, CJ; Camm, AJ; Nam, M | 1 |
| Michota, F | 1 |
| Huisman, MV; Kooiman, J; van de Peppel, WR; van der Meer, FJ | 1 |
| Crowther, M; Rochwerg, B; Spyropoulos, A; Xenodemetropoulos, T | 1 |
2 review(s) available for dabigatran and Chronic Disease
| Article | Year |
|---|---|
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Chronic Disease; Dabigatran; Drug Monitoring; Heart Failure; Hemorrhage; Humans; Morpholines; Outcome Assessment, Health Care; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Warfarin | 2014 |
Intracerebral hemorrhage: Pick your poison.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chronic Disease; Dabigatran; Humans; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Venous Thromboembolism; Warfarin | 2010 |
8 other study(ies) available for dabigatran and Chronic Disease
| Article | Year |
|---|---|
The prescription of direct oral anticoagulants in the elderly: An observational study of 19 798 Ambulatory subjects.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Blood Cell Count; Blood Coagulation Tests; Chronic Disease; Creatinine; Dabigatran; Drug Prescriptions; Female; France; Humans; Kidney Function Tests; Male; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban | 2020 |
Dabigatran-induced chronic progressive immune hemolytic anemia: A case report.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antithrombins; Chronic Disease; Dabigatran; Disease Progression; Drug Substitution; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Male; Treatment Outcome; Warfarin | 2020 |
Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Deep Venous Thrombosis in the Chronic Phase.
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Chronic Disease; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Pyrazoles; Pyridines; Pyridones; Recurrence; Thiazoles; Treatment Outcome; Ultrasonography; Venous Thrombosis; Warfarin | 2018 |
Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension.
Topics: Administration, Oral; Adult; Aged; Antithrombins; Chronic Disease; Dabigatran; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Reproducibility of Results; Treatment Outcome; Vitamin K | 2018 |
Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chronic Disease; Comorbidity; Dabigatran; Dementia; Dicumarol; Disabled Persons; Follow-Up Studies; Hemorrhage; Humans; Mobility Limitation; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Vitamin K | 2018 |
Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chronic Disease; Comorbidity; Dabigatran; Female; Humans; Male; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Treatment Outcome; United States; Warfarin | 2018 |
Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.
Topics: Administration, Oral; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biomarkers; Chronic Disease; Creatinine; Dabigatran; Fibrinolytic Agents; Glomerular Filtration Rate; Humans; Incidence; Kidney; Kidney Diseases; Morpholines; Netherlands; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Severity of Illness Index; Thiophenes | 2011 |
Dabigatran-induced acute hepatitis.
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Chemical and Drug Induced Liver Injury; Chronic Disease; Dabigatran; Humans; Male | 2012 |